| Entry |
|
|---|
| Name |
Fadrozole (INN) |
|---|
| Formula |
C14H13N3
|
|---|
| Exact mass |
223.1109
|
|---|
| Mol weight |
223.27
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG01596 Aromatase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Estrogen biosynthesis inhibitor |
|---|
| Comment |
Aromatase inhibitor
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01596 Aromatase inhibitor
DG01292 Fadrozole
D07940 Fadrozole
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Cytochrome P450
CYP19A1 (ARO)
D07940 Fadrozole (INN)
Drug groups [BR:br08330]
Antineoplastic
DG01596 Aromatase inhibitor
DG01292 Fadrozole
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8y C 24.0100 -19.0400
2 C8x C 23.3100 -17.8500
3 C8x C 21.9100 -17.8500
4 C8y C 21.2100 -19.0400
5 C8x C 21.9100 -20.2300
6 C8x C 23.3100 -20.2300
7 N4y N 26.1100 -17.8500
8 C1y C 25.4100 -19.0400
9 C1x C 26.1100 -20.2300
10 C1x C 27.5100 -20.2300
11 C1x C 28.1400 -19.0400
12 C8y C 27.5100 -17.8500
13 C8x C 27.9300 -16.4500
14 N5x N 26.8100 -15.6800
15 C8x C 25.6900 -16.4500
16 C3b C 19.8100 -19.0400
17 N3a N 18.4100 -19.0400
BOND 19
1 3 4 1
2 4 5 2
3 7 8 1
4 8 9 1
5 9 10 1
6 10 11 1
7 11 12 1
8 12 7 1
9 5 6 1
10 6 1 2
11 12 13 2
12 13 14 1
13 14 15 2
14 15 7 1
15 8 1 1
16 4 16 1
17 1 2 1
18 16 17 3
19 2 3 2
|
|---|
